273196-12-6 Usage
General Description
3-(2-naphthalen-2-yl-2-oxo-ethylidene)-3,4-dihydro-1H-quinoxalin-2-one is a chemical compound with a complex molecular structure. It contains a naphthalene ring, an oxo group, and a quinoxalinone ring. The compound is a quinoline derivative and has potential pharmaceutical applications due to its structural features and potential biological activities. Its molecular structure suggests that it could have diverse properties, including potential anti-inflammatory, antioxidant, and anti-cancer activities. Further research and studies may be needed to fully understand its potential uses and mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 273196-12-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,3,1,9 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 273196-12:
(8*2)+(7*7)+(6*3)+(5*1)+(4*9)+(3*6)+(2*1)+(1*2)=146
146 % 10 = 6
So 273196-12-6 is a valid CAS Registry Number.
InChI:InChI=1/C20H14N2O2/c23-19(15-10-9-13-5-1-2-6-14(13)11-15)12-18-20(24)22-17-8-4-3-7-16(17)21-18/h1-12,21H,(H,22,24)/b18-12-
273196-12-6Relevant articles and documents
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors
Dou, Xiaodong,Huang, Huixia,Jiang, Lan,Jiao, Ning,Jin, Hongwei,Liu, Zhenming,Zhang, Liangren,Zhang, Lihe,Zhu, Guiwang
, (2020/07/03)
The c-Jun N-terminal kinase 3 (JNK3) plays key roles in a wide range of diseases, including neurodegeneration diseases, inflammation diseases, cancers, cardiovascular diseases, and metabolic disorders. Previously, we have identified a lead compound, (Z)-3
